The RCP is delighted that Clinical Medicine’s impact factor (for 2021 citations of content published in 2019 and 2020) has gone up from 2.66 to 5.41.
While most medical journals have seen impact factors rise with the ‘COVID effect’, ClinMed’s relative position in the ‘Medicine, General and Internal’ category (which includes The Lancet, New England Journal of Medicine, BMJ and JAMA) has moved up to #45 out of 172 titles (from 61st percentile to 74th percentile).
During the first wave of the pandemic, ClinMed introduced a new rapid workflow for articles that support clinical practice and share clinical observations. Highly cited articles were on aspects of COVID-19 including an early article on current knowledge of the virus, vitamin D, obesity and nutritional status, PPE and nosocomial transmission, thrombosis, post-COVID rehabilitation, and complications such as rhombencephalitis, Guillain-Barré syndrome and pneumomediastinum.
ClinMed downloads increased by 73% between 2019 and 2020; this increase in profile will have boosted the citations of non-COVID content as well as COVID content, with well-cited articles on topics including neuromyelitis optica, prehabilitation, pyoderma gangrenosum and obesity. ClinMed submissions tripled during 2020 and while publication volume doubled, we were able to increase our selectivity, which will also have helped to boost our impact.
RCP medical director of publishing Anton Emmanuel said:
‘The release of journal impact factor every year is a big day for many journal teams. In ClinMed this is not our primary focus, but nevertheless it is pleasing to see that we have continued an upward trend in this metric. This is especially so given that we’ve moved in the past 12 months to entirely online editions, implying that the quality of our content continues to improve. We are grateful to our authors and editorial team for this, and hope our all-time high impact factor brings in new readers and authors.’